九安医疗(002432.SZ)：在持续血糖监测（CGM）领域，公司已完成多批次试生产

Core Viewpoint - The company has completed multiple batches of trial production in the continuous glucose monitoring (CGM) field and is actively conducting domestic testing and clinical work while advancing the development of CGM products for international markets [1] Group 1: Product Development - The company is focusing on the development of CGM products, which are crucial for diabetes management [1] - The CGM products will be integrated into a new "O+O" model for diabetes diagnosis and care, enhancing the company's core strategic implementation and development [1] Group 2: Market Strategy - The company aims to deepen its service in the "O+O" model, which is expected to create high-frequency customer engagement and generate synergistic effects [1]